Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moorcroft, A J
Right arrow Articles by Webb, A K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moorcroft, A J
Right arrow Articles by Webb, A K
Thorax 2004;59:1074-1080
© 2004 BMJ Publishing Group Ltd & British Thoracic Society


CYSTIC FIBROSIS

Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial

A J Moorcroft1, M E Dodd2, J Morris3, A K Webb2

1 The Royal Shrewsbury Hospital, Shrewsbury SY3 8XQ, UK
2 Manchester Adult CF Centre, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital, Manchester M23 9LT, UK
3 Wythenshawe Hospital, Manchester M23 9LT, UK

Correspondence to:
Correspondence to:
Professor A K Webb
Manchester Adult CF Centre, South Manchester University Hospitals NHS Trust, Wythenshawe Hospital, Manchester M23 9LT, UK; the5webbs{at}hotmail.com

Background: Short term studies of exercise training have shown benefits in cystic fibrosis. Transferring exercise programmes to the community and sustaining them long term is a challenge for the patient. The effectiveness of an individualised unsupervised home based exercise programme was examined in adults with cystic fibrosis over a 1 year period.

Methods: Subjects were randomised to undertake three sessions per week of upper and lower body exercise based on individualised preferences (n = 30) or to a control group (n = 18). They were evaluated at baseline and at 12 months. The primary outcome measure was improved fitness as assessed by change in blood lactate concentration at the end of an identical constant work rate for both arm and leg ergometric testing. Secondary outcome measurements were heart rate and pulmonary function.

Results: For leg exercise, significant differences were seen at 12 months between the active and control groups in the mean (SE) change in blood lactate levels (–0.38 (0.23) mmol/l v 0.45 (0.25) mmol/l, p<0.05) and heart rate (–4.8 (2.5) bpm v 3.4 (2.5) bpm, p<0.05), confirming a training effect. For arm ergometry there was no change in lactate levels at 12 months but there was a significant difference in forced vital capacity (46 (72) ml v –167 (68) ml, p<0.05).

Conclusions: A training effect, as measured by a reduction in lactate levels and heart rate, can be achieved with unsupervised individualised home exercise in adults with cystic fibrosis. A benefit to pulmonary function was observed and together these findings suggest that exercise programmes should be encouraged as an important component of care in cystic fibrosis.


Abbreviations: BMI, body mass index; CF, cystic fibrosis; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; HR, heart rate; RER, respiratory exchange ratio; RR, respiratory rate; SaO2, oxygen saturation; VE, ventilation; VO2, oxygen consumption

Keywords: exercise training; lactate; symptoms; cystic fibrosis; pulmonary function




This article has been cited by other articles:


Home page
Clin RehabilHome page
W. D. Reid, E. L. Geddes, K. O'Brien, D. Brooks, and J. Crowe
Effects of inspiratory muscle training in cystic fibrosis: a systematic review
Clinical Rehabilitation, October 1, 2008; 22(10-11): 1003 - 1013.
[Abstract] [PDF]


Home page
J Pediatr PsycholHome page
R. S. Bernard, L. L. Cohen, and K. Moffett
A Token Economy for Exercise Adherence in Pediatric Cystic Fibrosis: A Single-Subject Analysis
J. Pediatr. Psychol., September 26, 2008; (2008) jsn101v1.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. Schnabel, C. Grasemann, D. Staab, H. Wollmann, F. Ratjen, and for the German Cystic Fibrosis Growth Hormone Stud
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Metabolic and Respiratory Effects of Growth Hormone in Children With Cystic Fibrosis
Pediatrics, June 1, 2007; 119(6): e1230 - e1238.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. L. Ries, G. S. Bauldoff, B. W. Carlin, R. Casaburi, C. F. Emery, D. A. Mahler, B. Make, C. L. Rochester, R. ZuWallack, and C. Herrerias
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines
Chest, May 1, 2007; 131(5_suppl): 4S - 42S.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
H. Hebestreit, S. Kieser, S. Rudiger, T. Schenk, S. Junge, A. Hebestreit, M. Ballmann, H-G. Posselt, and S. Kriemler
Physical activity is independently related to aerobic capacity in cystic fibrosis
Eur. Respir. J., October 1, 2006; 28(4): 734 - 739.
[Abstract] [Full Text] [PDF]


Home page
Chronic Respiratory DiseaseHome page
M E Dodd and S A Prasad
Physiotherapy management of cystic fibrosis
Chronic Respiratory Disease, July 1, 2005; 2(3): 139 - 149.
[Abstract] [PDF]


Home page
Eur Respir JHome page
A. J. Moorcroft, M. E. Dodd, J. Morris, and A. K. Webb
Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis
Eur. Respir. J., June 1, 2005; 25(6): 1050 - 1056.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 BMJ Publishing Group Ltd & British Thoracic Society